NCT07512856Recruiting
The Implementation of a Trans-tailored Harm Reduction Service for Transgender Persons in Relation to chemsEX and Substance Use (iT-REX)
Source: ClinicalTrials.gov · Last updated 6 Apr 2026
Brief summary (registry, in English)
This study evaluates a comprehensive transgender-tailored harm reduction service for transgender women, transgender men, and non-binary individuals engaging in chemsex or substance use in Thailand, focusing on PrEP uptake, HIV/STI outcomes, mental health, and socio-legal impacts.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 140 (estimated)
- First submitted
- 22 Mar 2026
- Start date
- 1 Feb 2024
- Primary completion date
- 1 Feb 2027
- Lead sponsor
- Institute of HIV Research and Innovation Foundation, Thailand
- Diseases
- HIV
- NCT number
- NCT07512856
What you commit to
- Study type: Interventional
- Planned participants: 140
- From 1 Feb 2024 to the primary completion date, 1 Feb 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Inability to communicate in Thai sufficiently to complete study procedures
Who the study is looking for
- Self-identified transgender women, transgender men, or non-binary persons
- Age ≥18 years
- HIV-negative
- Engaged in chemsex or substance use within past 12 months
- Able to provide informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Tangerine Clinic, Institute of HIV Research and Innovation Coordinator of this site? Confirm its status | Pathum Wan | Thailand | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.